Funding the future of cancer research

We are enabling six talented young doctors to take time out from their clinical studies to carry out vital research into the treatment of blood cancers.

We’re dedicated to

Funding the next generation of cancer research scientists, and exploring how the body's own immune system can be used to attach cancer tumours (immunotherapy).

The difference we’re making

  • Funding six clinical research fellows at the Centre for Haemato-Oncology at Barts and the London School of Medicine and Dentistry (SMD)
  • Nurturing new research talent under the supervision of leading cancer consultant and researcher Professor John Gribben
  • Advancing knowledge into the effectiveness of immunotherapy
See how you can make a difference too

What the researchers are saying

“I genuinely think these new treatments could revolutionise cancer medicine. I believe that we'll soon look back at chemotherapy the way we now think of leeches...”

– Professor John Gribben, Centre Lead Centre for Haemato-Oncology SMD and Consultant Haematologist Barts Health (pictured second left)




Funding extraordinary healthcare

The battle against cancer is ongoing.  Even though we are making progress every day, we need to ensure that the researchers of the future have the time, resources and expert guidance to make the next breakthroughs.


You can contribute to extraordinary projects like this

Donate now

More like this


New “PlasmaJet” equipment is helping staff treat patients with advanced ovarian cancer. It works like a surgical “blowtorch”, enabling staff to remove tissue from tricky locations.